What is the pathology of nephrolithiasis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: July 20, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Pathology of Nephrolithiasis

Nephrolithiasis is a condition in which kidney stones form from crystals precipitating in the urine when the urinary concentration of crystal-forming substances is high or when inhibitors of stone formation are low. 1

Stone Composition and Prevalence

  • Approximately 80% of kidney stones consist primarily of calcium oxalate, calcium phosphate, or both
  • Other stone types include struvite, uric acid, and cystine 1
  • Lifetime prevalence: 13% for men and 7% for women
  • 5-year recurrence rate after an initial event: 35-50% without treatment 1

Pathophysiological Mechanism

The formation of kidney stones involves a complex multistep process:

  1. Supersaturation: The initial step where stone-forming salts exceed their solubility in urine 2
  2. Nucleation: Formation of crystal nidus when supersaturation reaches critical levels
  3. Crystal growth: Enlargement of crystals through addition of constituents
  4. Crystal aggregation: Clustering of crystals to form larger particles
  5. Crystal retention: Adherence to renal epithelium and continued growth 2

Key Factors in Stone Formation

Promoters of Stone Formation

  • Low urine volume: Increases concentration of stone-forming substances 1, 2
  • Low urine pH: Particularly important for uric acid stones 2
  • High urinary calcium (hypercalciuria): The greatest risk factor for calcium stone formation 3
  • High urinary oxalate (hyperoxaluria): Contributes to calcium oxalate stone formation 1, 2
  • High urinary sodium: Reduces renal tubular calcium reabsorption 1
  • High urinary urate: Promotes calcium oxalate crystallization 2

Inhibitors of Stone Formation

  • Citrate: Binds with calcium, reducing free calcium available for stone formation 1, 2
  • Magnesium: Forms complexes with oxalate, reducing calcium oxalate supersaturation 2
  • Organic substances: Including nephrocalcin, urinary prothrombin fragment-1, and osteopontin 2
  • Potassium: Associated with citrate metabolism; hypokalemia decreases urinary citrate 1

Pathophysiological Subtypes

Calcium Stone Formation

  • Hypercalciuria mechanisms 3:

    • Enhanced intestinal calcium absorption
    • Increased bone resorption
    • Altered renal tubular calcium transport
  • Dietary factors:

    • Low dietary calcium paradoxically increases risk by reducing binding of oxalate in the gut 1
    • High sodium intake increases urinary calcium excretion 1
    • High animal protein intake increases urinary calcium and decreases citrate 1

Infection-Related Stones (Struvite)

  • Caused by urease-producing bacteria (e.g., Proteus, Klebsiella)
  • Urease splits urea into ammonia, raising urine pH and promoting struvite crystal formation
  • These stones can grow rapidly and form "staghorn calculi" that fill the renal collecting system 4

Uric Acid Stones

  • Form in persistently acidic urine (pH < 5.5)
  • Associated with high purine intake and conditions with high cell turnover 5

Cystine Stones

  • Result from genetic defect in renal tubular cystine transport
  • Form in patients with cystinuria, a hereditary disorder 5

Environmental and Genetic Factors

  • Stone formation results from an interaction between genetics and environmental exposure 1
  • Dietary habits significantly influence stone risk 6
  • Variations in intestinal oxalate absorption exist between individuals 1
  • Some patients may have deficiency of Oxalobacter formigenes in the gut, which normally degrades oxalate 1

Clinical Implications

The pathophysiology of nephrolithiasis explains why certain preventive measures are effective:

  • Increased fluid intake dilutes stone-forming substances 1
  • Normal dietary calcium (not low) helps bind oxalate in the gut 1
  • Limiting sodium and animal protein reduces urinary calcium 1
  • Thiazide diuretics, citrate supplements, and allopurinol can be effective pharmacologic interventions based on stone type 1

Understanding the pathology of nephrolithiasis is essential for implementing appropriate preventive strategies and reducing the significant morbidity associated with this common condition.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Mechanisms Underlying Calcium Nephrolithiasis.

Annual review of physiology, 2022

Research

Management of urinary tract infections associated with nephrolithiasis.

Current infectious disease reports, 2010

Research

Medical treatment of nephrolithiasis.

Endocrinology and metabolism clinics of North America, 2002

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.